Document is current
Any future updates will be listed below
-
Authors
Santoro, Nicole https://orcid.org/0000-0001-5705-8084
Schmid, Christoph https://orcid.org/0000-0001-7070-487X
de Witte, Moniek https://orcid.org/0000-0001-7470-2994
Roeven, Mieke W. H.
Potter, Victoria
Richardson, Deborah https://orcid.org/0000-0002-8858-923X
Schroeder, Thomas
Válková, Veronika
Clesham, Katherine
Loron, Sandrine
Passweg, Jakob https://orcid.org/0000-0001-7092-3351
Besley, Caroline
Gruhn, Bernd https://orcid.org/0000-0003-1862-0075
Hoogenboom, Jorinde D.
Mooyaart, Jarl E.
Sanchez-Ortega, Isabel https://orcid.org/0009-0005-5519-9154
Pagliuca, Simona
Simonetta, Federico
Battipaglia, Giorgia https://orcid.org/0000-0002-0695-3879
Guillaume, Thierry https://orcid.org/0000-0001-5482-8565
Hazenberg, Mette D.
Malard, Florent https://orcid.org/0000-0002-3474-0002
Kuball, Jürgen https://orcid.org/0000-0002-3914-7806
Ruggeri, Annalisa https://orcid.org/0000-0002-7261-2765
- License Information
-
More Information
Article History
Received: 30 October 2024
Revised: 10 February 2025
Accepted: 13 March 2025
First Online: 23 March 2025
Competing interests
: CS has received travel expenses or honoraria for participation in advisory boards, symposia or other scientific events by Novartis, Jazz Pharmaceutical, Neovii, Janssen, and Kite. FS institutional consulting fees from BMS/Celgene, Incyte, Kite/Gilead; speaker fees from Kite/Gilead, Incyte; travel support from Kite/Gilead, Novartis, AstraZeneca, Neovii, Janssen; research funding from Kite/Gilead, Novartis, BMS/Celgene. SP has received travel expenses or honoraria for participation in advisory boards, symposia, or other scientific events by Alexion, Novartis, Jazz Pharmaceutical, Therakos, OneLamda, Sobi as well as research funding by JANSSEN HORIZON program. JK has received grants from Novartis, Miltenyi Biotech, and Gadeta. JK was a Gadeta shareholder; patent licenses to Gadeta and Miltenyi Biotech. None of these disclosures construe a potential competitive interest with the research discussed in this article. All other co-authors declare no COI.
: The scientific board of the CTIWP of EBMT approved this study. All patients gave written informed consent for the use of their data. All methods were performed in accordance with the relevant guidelines and regulations.
